echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > JCI: Scientists discover a specific inflammatory signal associated with leukemia progression

    JCI: Scientists discover a specific inflammatory signal associated with leukemia progression

    • Last Update: 2022-09-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Myelodysplastic syndromes (MDS, Myelodysplastic syndromes) are age-related myeloid neoplasms with an increased risk of progression to acute myeloid leukemia (AML).


    In Myelodysplastic Syndrome (MDS), the inability of the patient's body to produce blood cells effectively may predispose the patient to develop acute myeloid leukemia.


     

    Scientists have discovered a specific inflammatory signal associated with the progression of leukemia


    Image credit: Journal of Clinical Investigation (2022).


    In the current study, the researchers conducted an in-depth study of genetically engineered mice with diseases closely related to MDS.


    Based on the results of the mouse study, the researchers analyzed the bone marrow characteristics of MDS patients and found that the expression of two receptors for IL-6 was significantly increased in high-risk MDS patients, but in patients with acute myeloid Not in low-risk patients with leukemia


    Taken together, these findings may suggest that targeting the IL-6 signaling pathway may hold promise as a potential therapy to prevent progression from MDS to acute myeloid leukemia in human patients


    Original source:

    Yang Mei, Kehan ​​Ren, Yijie Liu, et al.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.